Hematology-OncologyAMLBRAF mutation
BRAF Mutations in AML: Rare, Biologically Distinct, and Linked to Poor Outcomes
By MedXY|Jun 19, 2026
BRAF mutations occur in about 1% of AML and are usually non-V600 variants enriched in myelodysplasia-related disease. This cohort study found poor survival and suggested that current therapies, including venetoclax-based regimens, remain in
